MDxHealth (MDXH) Cash from Investing Activities (2021 - 2026)
MDxHealth (MDXH) posted Cash from Investing Activities of -$500000.0 for Q1 2026, up 97.54% sequentially from -$20.4 million in Q3 2025, and down 3946.15% YoY from $13000.0 in Q1 2025.
MDxHealth (MDXH) Cash from Investing Activities (2021 - 2026) Analysis & Trends
MDxHealth has reported Cash from Investing Activities for 5 years, with the latest figure at -$500000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 3946.15% year-over-year to -$500000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.4 million (down 6023.33% YoY) and the FY2025 annual result came in at -$18.6 million, down 1034.35% from the prior year.
- Cash from Investing Activities improved to -$500000.0 in Q1 2026 per MDXH's latest filing, from -$20.4 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $13000.0 in Q1 2025 and troughed at -$20.4 million in Q3 2025.
- A 4-year average of -$5.3 million and a median of -$465500.0 in 2022 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities slumped 156446.15% in 2025, then slumped 3946.15% in 2026.
- Over 4 years, Cash from Investing Activities stood at -$431000.0 in 2022, then soared by 46.87% to -$229000.0 in 2024, then sank by 8786.9% to -$20.4 million in 2025, then surged by 97.54% to -$500000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$500000.0, -$20.4 million, and -$19.6 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | MDxHealth | 36.03 Mn | 15.62 Mn | 17.89 Mn | -7.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.66 Mn |
| Jun 30, 2026 | -7.66 Mn |
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Sep 30, 2025 | -20.35 Mn |
| Sep 30, 2025 | -20.35 Mn |
| Jun 30, 2025 | -19.58 Mn |
| Jun 30, 2025 | -19.58 Mn |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -406,868.02 |
| Mar 31, 2024 | -406,868.02 |
| Dec 31, 2023 | -440,069.56 |
| Dec 31, 2023 | -440,069.56 |
| Mar 31, 2023 | -847,005.95 |
| Mar 31, 2023 | -847,005.95 |
| Dec 31, 2022 | -2.02 Mn |
| Dec 31, 2022 | -2.02 Mn |